Susquehanna International Group
LHDX

Susquehanna International Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Susquehanna International Group’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,521
Closed -$53K – 14841
2022
Q2 		$53K Sell
28,521
-38,871
-58% -$94.5K ﹤0.01% 11954
2022
Q1 		$241K Sell
67,392
-97,120
-59% -$477K ﹤0.01% 10795
2021
Q4 		$1.42M Buy
164,512
+56,541
+52% +$360K ﹤0.01% 6351
2021
Q3 		$821K Buy
107,971
+75,446
+232% +$636K ﹤0.01% 8070
2021
Q2 		$216K Buy
32,525
+11,431
+54% +$72.1K ﹤0.01% 11443
2021
Q1 		$255K Buy
+21,094
New +$418K ﹤0.01% 10949

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $867M AUM 16.97% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $342M AUM 17.59% 1-Year Est. Return